Burning Rock Biotech (BNR) Return on Capital Employed (2020 - 2026)
Burning Rock Biotech (BNR) posted quarterly Return on Capital Employed of 10.2% for Q1 2026, up 2960.0% year-over-year from 0.33% in Q1 2025, and down 6.23% quarter-over-quarter from 9.6% in Q4 2025.
Burning Rock Biotech (BNR) Return on Capital Employed (2020 - 2026) Analysis & Trends
Burning Rock Biotech's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 10.2% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 2960.0% year-over-year to 10.2%; the TTM figure through Mar 2026 stood at 10.2% (up 2960.0% YoY), while the FY2025 annual figure was 9.21%, up 4109.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 10.2%, down from 9.6% in the prior quarter.
- The five-year high for Return on Capital Employed was 9.6% in Q4 2025, with the low at 83.0% in Q4 2022.
- The 5-year median for Return on Capital Employed is 59.43% (2024), against an average of 56.18%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed tumbled 4289 bps in 2022, then soared 5419 bps in 2025.
- Burning Rock Biotech's Return on Capital Employed stood at 83.0% in 2022, then grew by 2 bps to 81.4% in 2023, then surged by 36 bps to 52.21% in 2024, then surged by 82 bps to 9.6% in 2025, then retreated by 6 bps to 10.2% in 2026.
- Business Quant data shows BNR's Return on Capital Employed at 10.2% in Q1 2026, 9.6% in Q4 2025, and 21.07% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 6.42% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -13.91% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 10.49% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 68.60% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 49.80% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.97% |
| 10 | Burning Rock Biotech | 84.09 Mn | 14.24 Mn | 11.31 Mn | -10.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.15% |
| Dec 31, 2025 | -9.56% |
| Sep 30, 2025 | -21.03% |
| Jun 30, 2025 | -24.19% |
| Mar 31, 2025 | -39.87% |
| Dec 31, 2024 | -52.27% |
| Sep 30, 2024 | -59.49% |
| Jun 30, 2024 | -78.46% |
| Mar 31, 2024 | -80.66% |
| Dec 31, 2023 | -82.06% |
| Sep 30, 2023 | -78.44% |
| Jun 30, 2023 | -76.19% |
| Mar 31, 2023 | -80.97% |
| Dec 31, 2022 | -82.97% |
| Sep 30, 2022 | -73.30% |
| Jun 30, 2022 | -58.51% |
| Mar 31, 2022 | -49.33% |
| Dec 31, 2021 | -40.11% |
| Sep 30, 2021 | -31.99% |
| Jun 30, 2021 | -28.12% |